The B+ Foundation has opened their grant competition for two-year grants at $150,000 USD (10-12 available). Open to Canadian researchers. Competition closes 15-Sept-2017.

The Andrew McDonough B+ Foundation is proud to announce the 2017 Research Grant Cycle is now open.

Applications can be submitted at Proposal Central from June 1 to September 15, 2017  Our Scientific Advisory Board will then review applications and award 10-12 two-year grants of $75,000/year for a total award of $150,000 each.

Love golf, dinner and/or silent auctions? Live in the general Ottawa area? Register for the Aug 12 Annual Phoebe Rose Rocks Foundation Golf Tournament … or just for the dinner/auction. Register by July 28th.

Registration is now open for the second Annual Phoebe Rose Rocks Foundation Golf Tournament! Join us for a golf tournament on August 12th at Mont Cascades Golf Course. Make sure to register early so you don’t miss this great event!

Not a golfer? Register just for dinner!

To Register visit:

For information about hole sponsorship or to donate to the silent auction, please contact Robin Doull at:

The Phoebe Rose Rocks Foundation was founded in 2016 in memory of Phoebe Rose Doull-Hoffman to raise awareness and funds for childhood cancer research. Phoebe’s family and community established the Phoebe Rose Rocks Foundation to foster positive change within the childhood cancer community. Our mission is to support families who need to travel for treatment (more than 200kms) and to raise funds for childhood cancer research with a specific focus on difficult to treat and cure childhood cancers. For example: infant leukemia, acute myeloid leukemia, pediatric brain tumors.

The Phoebe Rose Rocks Foundation became an official registered charity with the Canada Revenue Agency in April, 2017. We are just getting started! Stay tuned for news on our progress, financials and strategic plan!

We would love to hear from you!

Connect with us:


TACL 2014-001 now open at Sick Kids (also open at Ste-Justine and BC Children’s):  A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma.  For more information see:


The July 2017 NAIT newsletter can be found HERE..

For more information on current and upcoming trials, please visit or send an email directly to

Solid Tumours: Dr. Daniel Morgenstern
Leukemia/Lymphoma: Dr. Jim Whitlock
CNS: Dr. Eric Bouffet
Patient Navigator: Karen Fung

BOOKMARK NAIT:  The current list of all open trials can be found on the NAIT Website at

HELPING FAMILIES NAVIGATE:  To assist patients and families with their transition, our Patient Navigator Program will collaborate with your team and the family to provide assistance with issues related to travel, accommodation, and navigating their way around the hospital and in the city. Furthermore, for patients living outside of Ontario, our Patient Navigator will assist physicians in completing an Out-of-Province Prior Approval Application to the Provincial Ministry of Health.

The vision of the New Agents and Innovative Therapy Program (NAIT) supports The Garron Cancer Centre and Sick Kids’ commitment to innovation and providing Canadian children and their families living with cancer with greater access to the best and newest treatment that will assist to improve clinical care.

Would you like $1000? If you are a non-MD healthcare professional working in peds hem/onc/BMT, you are eligible to apply for $1000 off-set the cost of attending a work-related conference. Applications due Nov 1 and May 1, annually.

See the Norma Auger application form available HERE; includes additional eligibility and instruction. 

The goal of the C17 Norma Auger Education Fund is to support health professionals involved in pediatric Oncology/Hematology/BMT across Canada advance their knowledge, skills and experience and to promote presentations and knowledge translation by these health professionals.  This is an annual scholarship offered by the C17 Education Committee with funding from the Childhood Cancer Canada Foundation.

Eligibility: Non-MD Pediatric Oncology/Hematology/BMT health care professionals working in Canada.

Application deadlines:  May 1st and November 1st annually  Selection Process: Applications will be reviewed by the C17 Education Committee.  Successful applicants will be notified in writing by December 1st and June 1st.

JOB POSTING: Clinical Trials Unit Manager at BC Children’s hem/onc – available immediately.

For a detailed job description, pay scale, and to apply, go to

Qualifications: Undergraduate degree in a relevant discipline. Post-graduate degree in related discipline or equivalent professional designation preferred. Certified Clinical Research Professional through SoCRA or ACRP preferred. Minimum of three years experience or the equivalent combination of education and experience. Additional qualifications listed in posting.

Job Summary: To oversee clinical trials unit operations and ensure the highest ethical and regulatory standards are followed while conducting clinical trials at BC Children’s Hospital.

This position is the functional interface between the Director/Principal Investigators in the Division of Oncology/Hematology/BMT and the Clinical Trials Unit (CTU). This position will be the providing vision and will be responsible for developing and strategically planning programs from conception to completion as well as managing clinical multi-research, multi-disciplinary projects the operational clinical trials manager within the Division of Pediatric Hematology/Oncology/BMT and Childhood Cancer and Blood Research Cluster.

The individual will be accountable for the execution of clinical protocols within the allocated budget, personnel resources and timelines and will bring operational knowledge to the translation of clinical research protocols into practice. The individual will contribute to the leadership of the department by providing guidance and direction to colleagues to ensure the successful achievement of the department goals and milestones. The individual will also maintain a high level of current knowledge in clinical trials in order to provide expertise to different parts of the Clinical Research Support Group.

In addition to areas of the hospital, outpatient visits are performed in the clinical offices, and research recording and communication occurs with the research office. Attendance at clinical rounds and study meetings occur frequently and travel to international conferences and study meetings may occur. The manager attends study and other meetings along with or on behalf of the Director and Research Program Manager.



NEW⇒C17 Operating and Ewing Sarcoma Grant Competition. Registration due 08-Sep-17. Grants due 29-Sep-17. All areas of research welcome. Spread the word!!

C17 is pleased to announce a SUPPLEMENTAL GRANT COMPETITION for both the C17 Research Network Operating Grant Competition (Round 20) and the Ewing Sarcoma Grant Competition (Round 5). This competition does not replace the regular fall competition.  It is an additional funding opportunity.

The C17 operating grant competition is focused on multicenter, multidisciplinary pediatric oncology/hematology research. The Ewing Sarcoma Competition is focused on research with a direct application into the causes, treatment, cure and quality of life for young people with Ewing Sarcoma.

Forms and documents can be found attached as linked above, and can be downloaded from under Committees> Research Network.

If you have any questions, please contact the C17 Research Network Coordinator, Leah C. Young, Ph.D.  leah.young2 (at)

CAN YOU RECOGNIZE THE SYMPTOMS OF THE DICER1 SYNDROME? New DICER1 online resource physicians and patients, including variant maps, biobanking instructions and genetic testing.

With over 50 years of combined research experience, clinician-researchers Dr. William Foulkes and Dr. David Malkin, are pleased to introduce a new resource for patients and healthcare professionals interested in learning more about DICER1 syndrome. Until now, our research has contributed to allowing caregivers recognize the major features of the syndrome, counsel families about the mutation status in their families, and offer surveillance for certain conditions that can occur in those carrying DICER1 mutations. However, due to the rarity of DICER1 syndrome and related tumors, the study of DICER1 syndrome has been limited by the number of cases which occur. This Canadian research network will work to provide an international resource for the dissemination of the information that has been learned about DICER1 syndrome (available in English, French, and Spanish), a DICER1 sample database available for researchers at no cost, and a tool for broadening our reach for case and specimen collection. Please visit our website ( or contact Evan Weber ( for more information.

JOB POSTING: Research Program Manager at UBC/BC Children’s Hospital (open until filled, immediate start available)

The University of British Columbia, Department of Pediatrics, located at BCCH is seeking a Research Program Manager to provide strategic direction of the and MCCCRP and CCBR Group at the BC Children’s Hospital Research Institute in close collaboration with the program director, Dr. Kirk Schultz. You will be responsible for the overall planning, development, management, coordination, and communication for a large multiple-project clinical research program and laboratory research program; facilitation and management of research grants; writing reports and presentations for various stakeholders; developing drafts of manuscripts for publication; management of human
resources and financial administration; and contributing to the development of future research and programmatic activities.

The successful candidate will hold a Post-graduate degree or equivalent professional designation, a MSc or PhD is preferred. 4 years or equivalent combination of education and experience is required including experience in conducting clinical and laboratory research. Experience in financial management and human resource management is preferred. Experience with project management for multiple-site projects, research grants and contracts an asset.

Review of applications will commence immediately. Interested applicants should submit a letter and their curriculum vitae to:

Kirk R. Schultz, MD, FCAHS
Director, Michael Cuccione Childhood Cancer Research Program
Professor of Pediatrics, UBC
BC Children’s Hospital and Research Institute
4480 Oak Street, Rm. B315
Vancouver, BC V6H 3V4


Applications will be accepted until the position is filled. The anticipated start date is as soon as possible.  For a complete job description, please see or

The University of British Columbia (UBC) is Canada’s third largest university and consistently ranks among the 40 best universities in the world. Primarily situated in Vancouver, UBC is a research-intensive university and has an economic impact of $4 billion to the provincial economy. The UBC Faculty of Medicine educates health professional and life sciences students at the undergraduate, graduate and postgraduate levels, and pursues research – in the laboratory, in clinical settings and at the population and public policy level – to improve the health of people worldwide.

BC Children’s Hospital (BCCH) cares for the province’s most acutely ill or injured children and youth and pediatric patients with chronic medical disorders, and provides developmental and rehabilitation services to children and youth throughout BC. BCCH offers a wide range of health services and specialized health programs, is a leading acute care teaching facility, and conducts research to advance health and care through the BC Children’s Hospital Research Institute, in partnership with the UBC. The pediatric residency program and 16 pediatric subspecialty training programs are accredited by the Royal College of Physicians and Surgeons of Canada.

The Michael Cuccione Childhood Cancer research program (MCCCRP) is a program focused on improving the efficacy and safety of the treatment of childhood, adolescent, and young adult cancers. It focuses on developing targeted interventions including drug and immune therapies that include cell therapies including blood and marrow transplantation. Moreover there is a major focus on improving the safety of current therapies to lead to a minimum amount of late effects. The Childhood and Cancer and Blood (CCBR) group includes the MCCCRP as well as research focused on all blood disorders including transplantation and cell therapies for non-cancer diseases. The program is provincial in its scope and provides national and international leadership. The MCCCRP included 10 clinical trials PIs and 6 laboratory based PIs. The clinical trials program includes 7 clinical fellows, 10 CRAs and RNs with 3 managers as part of the program structure and the laboratory based program includes 40 trainees, RAs, post-doctoral fellows, and project coordinators. The CCBR include an additional 15 PIs involved in blood and cancer research. The approximate annual operating budget is $2M.

The INUIT CANCER EXPERIENCE depicted in “Jon’s Tricky Journey” (storybook+ educational resource) by Pat McCarthy, and funded by C17 with CCCF. All sites to receive copies. See full posting for book website with previews of this stunning book.

From the author, Pat McCarthy:


Hello everyone! This is my first e-mail blast to family, friends and colleagues. I wanted to let you know that my book has been published by Inhabit Media and is available on (US),  and on Indigo books (Canada). The amazon and indigo websites say release date of Sept 1 2017, however the books should be arriving in the Inhabit Media warehouse this week, and will be available sooner. The book is bilingual; English and Inuktitut.

My website is:

Inhabit Media website:

This book was supported with a grant from C17,  in partnership with Childhood Cancer Canada Foundation, and with support from the Children’s Hospital of Eastern Ontario.

Jon loves his life in the North. But when he feels a pain that won’t go away, he must go to a children’s hospital in the south to find out what is wrong. A doctor there tells Jon he has cancer and will have to stay at the hospital for a while.

Suddenly Jon’s life is upside down! But with a handful of tricks from the doctors and nurses, and new friends, Jon discovers ways to cope with some of the tricky parts of having cancer.

Accompanied by a resource guide for parents and caregivers, including hospital and support information, Jon’s Tricky Journey opens a conversation between Inuit children facing a cancer diagnosis and their families to help make a difficult and confusing time more manageable.

Written by Patricia McCarthy | Illustrated by Hwei Lim

ISBN: 978-1-77227-145-4 | $19.95 | 8.5″ x 8.5″ | 70 pages | Full-colour illustrations | Paperback | Bilingual Inuktitut and English

Ages 5–7


The NAIT June newsletter is available here: NAIT Newletter June 2017
The vision of the New Agents and Innovative Therapy Program (NAIT) supports The Garron Cancer Centre and SickKids’ commitment to innovation and providing Canadian children and their families living with cancer with greater access to the best and newest treatment that will assist to improve clinical